The position of combined medical treatment in acromegaly

Abstract

Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy.

What’s in a name? What we call growth hormone is much more than just a growth-related peptide

“…Coopmans and cols. (12) share with us the current position of combination medical therapy in acromegaly, based on the results of recent clinical studies and their own experience at the Erasmus Medical Center in Rotterdam. They discuss the potential additive and synergistic effects of the drugs and present what is currently known about efficacy and safety of this therapeutic modality.…”